NEW YORK (GenomeWeb) – Cambridge Epigenetix and NuGen Technologies have partnered to integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.

The companies said that the agreement will enable Cambridge to focus on its epigenetic biomarker discovery programs, both in house and in partnership with biopharma companies, while strengthening NuGen's whole-genome and targeted enrichment systems for epigenetic sequencing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.